These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 35269453)

  • 21. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
    Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
    EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.
    Wong PF; Dharmani M; Ramasamy TS
    Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reprogramming aging and progeria.
    Freije JM; López-Otín C
    Curr Opin Cell Biol; 2012 Dec; 24(6):757-64. PubMed ID: 22959961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Horizons in cellular senescence for clinicians.
    Witham MD; Granic A; Miwa S; Passos JF; Richardson GD; Sayer AA
    Age Ageing; 2023 Jul; 52(7):. PubMed ID: 37466640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of cellular senescence and SASP in tumour microenvironment.
    Takasugi M; Yoshida Y; Hara E; Ohtani N
    FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approaches towards Longevity: Reprogramming, Senolysis, and Improved Mitotic Competence as Anti-Aging Therapies.
    Melo Pereira S; Ribeiro R; Logarinho E
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30795536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology.
    Sogabe Y; Seno H; Yamamoto T; Yamada Y
    Cancer Sci; 2018 Sep; 109(9):2641-2650. PubMed ID: 29989289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice.
    Fielder E; Wan T; Alimohammadiha G; Ishaq A; Low E; Weigand BM; Kelly G; Parker C; Griffin B; Jurk D; Korolchuk VI; von Zglinicki T; Miwa S
    Elife; 2022 May; 11():. PubMed ID: 35507395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial dysfunction and cell senescence: deciphering a complex relationship.
    Chapman J; Fielder E; Passos JF
    FEBS Lett; 2019 Jul; 593(13):1566-1579. PubMed ID: 31211858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aging and reprogramming: a two-way street.
    Mahmoudi S; Brunet A
    Curr Opin Cell Biol; 2012 Dec; 24(6):744-56. PubMed ID: 23146768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of cellular senescence in skin ageing: A notion of mosaic and therapeutic strategies.
    Toutfaire M; Bauwens E; Debacq-Chainiaux F
    Biochem Pharmacol; 2017 Oct; 142():1-12. PubMed ID: 28408343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the SASP to combat ageing: Mitochondria as possible intracellular allies?
    Birch J; Passos JF
    Bioessays; 2017 May; 39(5):. PubMed ID: 28217839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis.
    Wagner KD; Wagner N
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissecting primary and secondary senescence to enable new senotherapeutic strategies.
    Admasu TD; Rae M; Stolzing A
    Ageing Res Rev; 2021 Sep; 70():101412. PubMed ID: 34302996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues.
    Alle Q; Le Borgne E; Milhavet O; Lemaitre JM
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular senescence: beneficial, harmful, and highly complex.
    Baker DJ; Narita M; Muñoz-Cánoves P
    FEBS J; 2023 Mar; 290(5):1156-1160. PubMed ID: 36856679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Aspects of Senescence and Organismal Ageing-DNA Damage Response, Telomeres, Inflammation and Chromatin.
    Sławińska N; Krupa R
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Senotherapy for lung diseases.
    Barnes PJ
    Adv Pharmacol; 2023; 98():249-271. PubMed ID: 37524489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.
    Tchkonia T; Zhu Y; van Deursen J; Campisi J; Kirkland JL
    J Clin Invest; 2013 Mar; 123(3):966-72. PubMed ID: 23454759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.